Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
(Reuters) -U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it announced last year. Investors have fled from Pfizer as pandemic worries declined and billions of dollars in COVID-19 vaccine and treatment …
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027 Read More »










